{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T04:06:22Z","timestamp":1791691582274,"version":"4.3.4"},"reference-count":71,"publisher":"Elsevier BV","issue":"25","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,22]],"date-time":"2020-08-22T00:00:00Z","timestamp":1598054400000},"content-version":"vor","delay-in-days":448,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"HHS | National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1074\/jbc.ra119.008930","type":"journal-article","created":{"date-parts":[[2019,5,16]],"date-time":"2019-05-16T01:45:13Z","timestamp":1557971113000},"page":"9973-9984","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":83,"title":["C-terminal \u03b1-synuclein truncations are linked to cysteine cathepsin activity in Parkinson\u2019s disease"],"prefix":"10.1016","volume":"294","author":[{"given":"Ryan P.","family":"McGlinchey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon M.","family":"Lacy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine E.","family":"Huffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahid","family":"Tayebi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Sidransky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0506-8349","authenticated-orcid":false,"given":"Jennifer C.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.RA119.008930_bib1","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.1073\/pnas.95.11.6469","article-title":"\u03b1-Synuclein in filamentous inclusions of Lewy bodies from Parkinson\u2019s disease and dementia with Lewy bodies","volume":"95","author":"Spillantini","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.RA119.008930_bib2","doi-asserted-by":"crossref","first-page":"29739","DOI":"10.1074\/jbc.M600933200","article-title":"Phosphorylation of Ser-129 is the dominant pathological modification of \u03b1-synuclein in familial and sporadic Lewy body disease","volume":"281","author":"Anderson","year":"2006","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA119.008930_bib3","doi-asserted-by":"crossref","first-page":"44405","DOI":"10.1074\/jbc.M308041200","article-title":"Ubiquitination of \u03b1-synuclein in Lewy bodies is a pathological event not associated with impairment of proteasome function","volume":"278","author":"Tofaris","year":"2003","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA119.008930_bib4","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.mcn.2013.01.004","article-title":"Oxidative stress-induced posttranslational modifications of \u03b1-synuclein: Specific modification of \u03b1-synuclein by 4-hydroxy-2-nonenal increases dopaminergic toxicity","volume":"54","author":"Xiang","year":"2013","journal-title":"Mol. Cell Neurosci"},{"key":"10.1074\/jbc.RA119.008930_bib5","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.1074\/mcp.R113.032730","article-title":"\u03b1-Synuclein post-translational modifications as potential biomarkers for Parkinson disease and other synucleinopathies","volume":"12","author":"Schmid","year":"2013","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1074\/jbc.RA119.008930_bib6","first-page":"879","article-title":"Aggregation of \u03b1-synuclein in Lewy bodies of sporadic Parkinson\u2019s disease and dementia with Lewy bodies","volume":"152","author":"Baba","year":"1998","journal-title":"Am. J. Pathol"},{"key":"10.1074\/jbc.RA119.008930_bib7","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.2353\/ajpath.2007.061232","article-title":"Calpain-cleavage of \u03b1-synuclein: Connecting proteolytic processing to disease-linked aggregation","volume":"170","author":"Dufty","year":"2007","journal-title":"Am. J. Pathol"},{"key":"10.1074\/jbc.RA119.008930_bib8","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1046\/j.1471-4159.2003.01878.x","article-title":"Distinct cleavage patterns of normal and pathologic forms of \u03b1-synuclein by calpain I in vitro","volume":"86","author":"Mishizen-Eberz","year":"2003","journal-title":"J. Neurochem"},{"key":"10.1074\/jbc.RA119.008930_bib9","doi-asserted-by":"crossref","first-page":"3975","DOI":"10.1093\/hmg\/ddu112","article-title":"Overexpression of the calpain-specific inhibitor calpastatin reduces human \u03b1-synuclein processing, aggregation and synaptic impairment in A30P \u03b1-syn transgenic mice","volume":"23","author":"Diepenbroek","year":"2014","journal-title":"Hum. Mol. Genet"},{"key":"10.1074\/jbc.RA119.008930_bib10","doi-asserted-by":"crossref","first-page":"9587","DOI":"10.1073\/pnas.1610099113","article-title":"Caspase-1 causes truncation and aggregation of the Parkinson\u2019s disease-associated protein \u03b1-synuclein","volume":"113","author":"Wang","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.RA119.008930_bib11","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.neulet.2008.02.057","article-title":"Cleavage of normal and pathological forms of \u03b1-synuclein by neurosin in vitro","volume":"436","author":"Kasai","year":"2008","journal-title":"Neurosci. Lett"},{"key":"10.1074\/jbc.RA119.008930_bib12","doi-asserted-by":"crossref","first-page":"5797","DOI":"10.1038\/srep05797","article-title":"Quantitative measurement of intact \u03b1-synuclein proteoforms from post-mortem control and Parkinson\u2019s disease brain tissue by intact protein mass spectrometry","volume":"4","author":"Kellie","year":"2014","journal-title":"Sci. Rep"},{"key":"10.1074\/jbc.RA119.008930_bib13","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1007\/s11064-011-0527-x","article-title":"Identification of novel \u03b1-synuclein isoforms in human brain tissue by using an online NanoLC-ESI-FTICR-MS method","volume":"36","author":"Ohrfelt","year":"2011","journal-title":"Neurochem. Res"},{"key":"10.1074\/jbc.RA119.008930_bib14","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1021\/bi020429y","article-title":"The N-terminal repeat domain of \u03b1-synuclein inhibits \u03b2-sheet and amyloid fibril formation","volume":"42","author":"Kessler","year":"2003","journal-title":"Biochemistry"},{"key":"10.1074\/jbc.RA119.008930_bib15","doi-asserted-by":"crossref","first-page":"13910","DOI":"10.1074\/jbc.RA118.001862","article-title":"The effect of truncation on prion-like properties of \u03b1-synuclein","volume":"293","author":"Terada","year":"2018","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA119.008930_bib16","doi-asserted-by":"crossref","first-page":"8530","DOI":"10.1021\/bi027363r","article-title":"Role of \u03b1-synuclein carboxy-terminus on fibril formation in vitro","volume":"42","author":"Murray","year":"2003","journal-title":"Biochemistry"},{"key":"10.1074\/jbc.RA119.008930_bib17","doi-asserted-by":"crossref","first-page":"5506","DOI":"10.1039\/C8SC01109E","article-title":"C-terminal truncation of \u03b1-synuclein promotes amyloid fibril amplification at physiological pH","volume":"9","author":"van der Wateren","year":"2018","journal-title":"Chem. Sci"},{"key":"10.1074\/jbc.RA119.008930_bib18","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0014-5793(98)01146-6","article-title":"Synthetic filaments assembled from C-terminally truncated \u03b1-synuclein","volume":"436","author":"Crowther","year":"1998","journal-title":"FEBS Lett"},{"key":"10.1074\/jbc.RA119.008930_bib19","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jmb.2011.05.046","article-title":"Conserved C-terminal charge exerts a profound influence on the aggregation rate of \u03b1-synuclein","volume":"411","author":"Levitan","year":"2011","journal-title":"J. Mol. Biol"},{"key":"10.1074\/jbc.RA119.008930_bib20","doi-asserted-by":"crossref","first-page":"16233","DOI":"10.1021\/bi048453u","article-title":"Impact of the acidic C-terminal region comprising amino acids 109\u2013140 on \u03b1-synuclein aggregation in vitro","volume":"43","author":"Hoyer","year":"2004","journal-title":"Biochemistry"},{"key":"10.1074\/jbc.RA119.008930_bib21","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1460-9568.2010.07284.x","article-title":"Co-expression of C-terminal truncated \u03b1-synuclein enhances full-length \u03b1-synuclein-induced pathology","volume":"32","author":"Ulusoy","year":"2010","journal-title":"Eur. J. Neurosci"},{"key":"10.1074\/jbc.RA119.008930_bib22","doi-asserted-by":"crossref","first-page":"22670","DOI":"10.1074\/jbc.M501508200","article-title":"A precipitating role for truncated \u03b1-synuclein and the proteasome in \u03b1-synuclein aggregation: Implications for pathogenesis of Parkinson disease","volume":"280","author":"Liu","year":"2005","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA119.008930_bib23","doi-asserted-by":"crossref","first-page":"9441","DOI":"10.1523\/JNEUROSCI.5314-13.2014","article-title":"Reducing C-terminal-truncated \u03b1-synuclein by immunotherapy attenuates neurodegeneration and propagation in Parkinson\u2019s disease-like models","volume":"34","author":"Games","year":"2014","journal-title":"J. Neurosci"},{"key":"10.1074\/jbc.RA119.008930_bib24","doi-asserted-by":"crossref","first-page":"25009","DOI":"10.1074\/jbc.M300227200","article-title":"\u03b1-Synuclein is degraded by both autophagy and the proteasome","volume":"278","author":"Webb","year":"2003","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA119.008930_bib25","doi-asserted-by":"crossref","first-page":"a006734","DOI":"10.1101\/cshperspect.a006734","article-title":"Integration of clearance mechanisms: The proteasome and autophagy","volume":"2","author":"Wong","year":"2010","journal-title":"Cold Spring Harb. Perspect. Biol"},{"key":"10.1074\/jbc.RA119.008930_bib26","doi-asserted-by":"crossref","first-page":"9678","DOI":"10.1021\/bi800699v","article-title":"Cathepsin D is the main lysosomal enzyme involved in the degradation of \u03b1-synuclein and generation of its carboxy-terminally truncated species","volume":"47","author":"Sevlever","year":"2008","journal-title":"Biochemistry"},{"key":"10.1074\/jbc.RA119.008930_bib27","doi-asserted-by":"crossref","first-page":"9322","DOI":"10.1073\/pnas.1500937112","article-title":"Cysteine cathepsins are essential in lysosomal degradation of \u03b1-synuclein","volume":"112","author":"McGlinchey","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.RA119.008930_bib28","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/nsmb.3433","article-title":"Asparagine endopeptidase cleaves \u03b1-synuclein and mediates pathologic activities in Parkinson\u2019s disease","volume":"24","author":"Zhang","year":"2017","journal-title":"Nat. Struct. Mol. Biol"},{"key":"10.1074\/jbc.RA119.008930_bib29","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.1021\/acs.biochem.7b00360","article-title":"Taking a bite out of amyloid: Mechanistic insights into \u03b1-synuclein degradation by cathepsin L","volume":"56","author":"McGlinchey","year":"2017","journal-title":"Biochemistry"},{"key":"10.1074\/jbc.RA119.008930_bib30","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.neulet.2010.11.068","article-title":"Parkinson's disease involves autophagy and abnormal distribution of cathepsin L","volume":"489","author":"Li","year":"2011","journal-title":"Neurosci. Lett"},{"key":"10.1074\/jbc.RA119.008930_bib31","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.nbd.2014.10.011","article-title":"Lysosomal enzyme cathepsin B enhances the aggregate forming activity of exogenous \u03b1-synuclein fibrils","volume":"73","author":"Tsujimura","year":"2015","journal-title":"Neurobiol. Dis"},{"key":"10.1074\/jbc.RA119.008930_bib32","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1038\/ng.3955","article-title":"A meta-analysis of genome-wide association studies identifies 17 new Parkinson\u2019s disease risk loci","volume":"49","author":"Chang","year":"2017","journal-title":"Nat. Genet"},{"key":"10.1074\/jbc.RA119.008930_bib33","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.neulet.2018.05.022","article-title":"Upregulation of PSMB8 and cathepsins in the human brains of dementia with Lewy bodies","volume":"678","author":"Ding","year":"2018","journal-title":"Neurosci. Lett"},{"key":"10.1074\/jbc.RA119.008930_bib34","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ymgme.2017.11.001","article-title":"Glucocerebrosidase haploinsufficiency in A53T \u03b1-synuclein mice impacts disease onset and course","volume":"122","author":"Tayebi","year":"2017","journal-title":"Mol. Genet. Metabol"},{"key":"10.1074\/jbc.RA119.008930_bib35","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1515\/revneuro-2012-0071","article-title":"The role of Ser129 phosphorylation of \u03b1-synuclein in neurodegeneration of Parkinson\u2019s disease: A review of in vivo models","volume":"24","author":"Sato","year":"2013","journal-title":"Rev. Neurosci"},{"key":"10.1074\/jbc.RA119.008930_bib36","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/0003-9861(88)90104-X","article-title":"Identification of latent procathepsins B and L in microsomal lumen: Characterization of enzymatic activation and proteolytic processing in vitro","volume":"261","author":"Nishimura","year":"1988","journal-title":"Arch. Biochem. Biophys"},{"key":"10.1074\/jbc.RA119.008930_bib37","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/(SICI)1097-0215(19960807)67:4<547::AID-IJC14>3.0.CO;2-4","article-title":"Activation of cathepsin B, secreted by a colorectal cancer cell line requires low pH and is mediated by cathepsin D","volume":"67","author":"van der Stappen","year":"1996","journal-title":"Int. J. Cancer"},{"key":"10.1074\/jbc.RA119.008930_bib38","doi-asserted-by":"crossref","first-page":"13482","DOI":"10.1074\/jbc.M117.780296","article-title":"Selective imaging of internalized proteopathic \u03b1-synuclein seeds in primary neurons reveals mechanistic insight into transmission of synucleinopathies","volume":"292","author":"Karpowicz","year":"2017","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA119.008930_bib39","doi-asserted-by":"crossref","first-page":"e0168700","DOI":"10.1371\/journal.pone.0168700","article-title":"Aggregated \u03b1-synuclein transfer efficiently between cultured human neuron-like cells and localize to lysosomes","volume":"11","author":"Domert","year":"2016","journal-title":"PLoS One"},{"key":"10.1074\/jbc.RA119.008930_bib40","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/s41598-018-35811-8","article-title":"Extracellular aggregated \u03b1-synuclein primarily triggers lysosomal dysfunction in neural cells prevented by trehalose","volume":"9","author":"Hoffmann","year":"2019","journal-title":"Sci. Rep"},{"key":"10.1074\/jbc.RA119.008930_bib41","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1073\/pnas.95.3.1265","article-title":"Improvement of neurological deficits in 6-hydroxydopamine-lesioned rats after transplantation with allogeneic simian virus 40 large tumor antigen gene-induced immortalized dopamine cells","volume":"95","author":"Clarkson","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.RA119.008930_bib42","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0076-6879(99)09020-5","article-title":"Quantification of \u03b2-sheet amyloid fibril structures with thioflavin T","volume":"309","author":"LeVine","year":"1999","journal-title":"Methods Enzymol"},{"key":"10.1074\/jbc.RA119.008930_bib43","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s12035-012-8341-2","article-title":"\u03b1-Synuclein and protein degradation systems: A reciprocal relationship","volume":"47","author":"Xilouri","year":"2013","journal-title":"Mol. Neurobiol"},{"key":"10.1074\/jbc.RA119.008930_bib44","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/mds.26562","article-title":"Lysosomal dysfunction and \u03b1-synuclein aggregation in Parkinson\u2019s disease: Diagnostic links","volume":"31","author":"Moors","year":"2016","journal-title":"Movement Disorders"},{"key":"10.1074\/jbc.RA119.008930_bib45","doi-asserted-by":"crossref","first-page":"8968","DOI":"10.1073\/pnas.132197599","article-title":"Human \u03b1-synuclein\u2013harboring familial Parkinson\u2019s disease-linked Ala-53 \u2192 Thr mutation causes neurodegenerative disease with \u03b1-synuclein aggregation in transgenic mice","volume":"99","author":"Lee","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.RA119.008930_bib46","doi-asserted-by":"crossref","first-page":"e62143","DOI":"10.1371\/journal.pone.0062143","article-title":"\u03b1-synuclein induces lysosomal rupture and cathepsin dependent reactive oxygen species following endocytosis","volume":"8","author":"Freeman","year":"2013","journal-title":"PLoS One"},{"key":"10.1074\/jbc.RA119.008930_bib47","doi-asserted-by":"crossref","first-page":"7690","DOI":"10.1038\/s41598-017-08149-w","article-title":"Impaired endo-lysosomal membrane integrity accelerates the seeding progression of \u03b1-synuclein aggregates","volume":"7","author":"Jiang","year":"2017","journal-title":"Sci. Rep"},{"key":"10.1074\/jbc.RA119.008930_bib48","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s00401-017-1722-x","article-title":"Endocytic vesicle rupture is a conserved mechanism of cellular invasion by amyloid proteins","volume":"134","author":"Flavin","year":"2017","journal-title":"Acta Neuropathol"},{"key":"10.1074\/jbc.RA119.008930_bib49","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.15252\/embj.201593411","article-title":"Tunneling nanotubes spread fibrillar \u03b1-synuclein by intercellular trafficking of lysosomes","volume":"35","author":"Abounit","year":"2016","journal-title":"EMBO J"},{"key":"10.1074\/jbc.RA119.008930_bib50","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.neuroscience.2011.10.042","article-title":"\u03b1-Synuclein phosphorylation and truncation are normal events in the adult human brain","volume":"200","author":"Muntan\u00e9","year":"2012","journal-title":"Neuroscience"},{"key":"10.1074\/jbc.RA119.008930_bib51","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1042\/BST20130158","article-title":"Emerging insights into the mechanistic link between \u03b1-synuclein and glucocerebrosidase in Parkinson\u2019s disease","volume":"41","author":"McGlinchey","year":"2013","journal-title":"Biochem. Soc. Trans"},{"key":"10.1074\/jbc.RA119.008930_bib52","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","article-title":"Multicenter analysis of glucocerebrosidase mutations in Parkinson\u2019s disease","volume":"361","author":"Sidransky","year":"2009","journal-title":"N. Engl. J. Med"},{"key":"10.1074\/jbc.RA119.008930_bib53","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1001\/jamaneurol.2013.1925","article-title":"A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies","volume":"70","author":"Nalls","year":"2013","journal-title":"JAMA Neurol"},{"key":"10.1074\/jbc.RA119.008930_bib54","doi-asserted-by":"crossref","first-page":"7441","DOI":"10.1523\/JNEUROSCI.0636-16.2016","article-title":"A new glucocerebrosidase chaperone reduces \u03b1-synuclein and glycolipid levels in IPSC-derived dopaminergic neurons from patients with Gaucher disease and Parkinsonism","volume":"36","author":"Aflaki","year":"2016","journal-title":"J. Neurosci"},{"key":"10.1074\/jbc.RA119.008930_bib55","doi-asserted-by":"crossref","first-page":"7693","DOI":"10.1523\/JNEUROSCI.0628-16.2016","article-title":"Activation of \u03b2-glucocerebrosidase reduces pathological \u03b1-synuclein and restores lysosomal function in Parkinson\u2019s patient midbrain neurons","volume":"36","author":"Mazzulli","year":"2016","journal-title":"J. Neurosci"},{"key":"10.1074\/jbc.RA119.008930_bib56","doi-asserted-by":"crossref","first-page":"12101","DOI":"10.1073\/pnas.1108197108","article-title":"CNS expression of glucocerebrosidase corrects \u03b1-synuclein pathology and memory in a mouse model of Gaucher-related synucleinopathy","volume":"108","author":"Sardi","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.RA119.008930_bib57","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1073\/pnas.1220464110","article-title":"Augmenting CNS glucocerebrosidase activity as a therapeutic strategy for parkinsonism and other Gaucher-related synucleinopathies","volume":"110","author":"Sardi","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.RA119.008930_bib58","doi-asserted-by":"crossref","first-page":"4755","DOI":"10.1038\/ncomms5755","article-title":"Glucocerebrosidase depletion enhances cell-to-cell transmission of \u03b1-synuclein","volume":"5","author":"Bae","year":"2014","journal-title":"Nat. Commun"},{"key":"10.1074\/jbc.RA119.008930_bib59","doi-asserted-by":"crossref","first-page":"28080","DOI":"10.1074\/jbc.M111.237859","article-title":"\u03b1-Synuclein interacts with glucocerebrosidase providing a molecular link between Parkinson and Gaucher diseases","volume":"286","author":"Yap","year":"2011","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA119.008930_bib60","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ymgme.2012.11.010","article-title":"Membrane-bound \u03b1-synuclein interacts with glucocerebrosidase and inhibits enzyme activity","volume":"108","author":"Yap","year":"2013","journal-title":"Mol. Genet. Metab"},{"key":"10.1074\/jbc.RA119.008930_bib61","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1074\/jbc.M114.610584","article-title":"Structural features of membrane-bound glucocerebrosidase and \u03b1-synuclein probed by neutron reflectometry and fluorescence spectroscopy","volume":"290","author":"Yap","year":"2015","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA119.008930_bib62","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0014-5793(94)00395-5","article-title":"Identification of 2 distinct synucleins from human brain","volume":"345","author":"Jakes","year":"1994","journal-title":"FEBS Letters"},{"key":"10.1074\/jbc.RA119.008930_bib63","doi-asserted-by":"crossref","first-page":"e15801","DOI":"10.1371\/journal.pone.0015801","article-title":"Targeted amino-terminal acetylation of recombinant proteins in E. coli","volume":"5","author":"Johnson","year":"2010","journal-title":"PLoS One"},{"key":"10.1074\/jbc.RA119.008930_bib64","doi-asserted-by":"crossref","first-page":"4615","DOI":"10.1021\/jp908092e","article-title":"Tryptophan probes at the \u03b1-synuclein and membrane interface","volume":"114","author":"Pfefferkorn","year":"2010","journal-title":"J. Phys. Chem. B"},{"key":"10.1074\/jbc.RA119.008930_bib65","doi-asserted-by":"crossref","first-page":"27258","DOI":"10.1016\/S0021-9258(19)61505-X","article-title":"Oxidation of either methionine 351 or methionine 358 in \u03b11-antitrypsin causes loss of anti-neutrophil elastase activity","volume":"275","author":"Taggart","year":"2000","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA119.008930_bib66","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0021-9673(95)00175-M","article-title":"Enhanced sensitivity for peptide-mapping with electrospray liquid-chromatography mass-spectrometry in the presence of signal suppression due to trifluoroacetic acid-containing mobile phases","volume":"712","author":"Apffel","year":"1995","journal-title":"J. Chromatogr. A"},{"key":"10.1074\/jbc.RA119.008930_bib67","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"FIJI: An open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1074\/jbc.RA119.008930_bib68","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.1038\/s41467-018-05971-2","article-title":"Cryo-EM of full-length \u03b1-synuclein reveals fibril polymorphs with a common structural kernel","volume":"9","author":"Li","year":"2018","journal-title":"Nat. Commun"},{"key":"10.1074\/jbc.RA119.008930_bib69","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/s41422-018-0075-x","article-title":"Amyloid fibril structure of \u03b1-synuclein determined by cryoelectron microscopy","volume":"28","author":"Li","year":"2018","journal-title":"Cell Res"},{"key":"10.1074\/jbc.RA119.008930_bib70","doi-asserted-by":"crossref","first-page":"e36402","DOI":"10.7554\/eLife.36402","article-title":"Cryo-EM structure of \u03b1-synuclein fibrils","volume":"7","author":"Guerrero-Ferreira","year":"2018","journal-title":"eLife"},{"key":"10.1074\/jbc.RA119.008930_bib71","article-title":"The making of a Lewy body: the role of \u03b1-synuclein post-fibrillization modifications in regulating the formation and the maturation of pathological inclusions","author":"Mahul-Mellier","year":"2018","journal-title":"bioRxiv"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820347256?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820347256?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.RA119.008930","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,25]],"date-time":"2022-09-25T06:59:25Z","timestamp":1664089165000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925820347256"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":71,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S0021925820347256"],"URL":"https:\/\/doi.org\/10.1074\/jbc.ra119.008930","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"C-terminal \u03b1-synuclein truncations are linked to cysteine cathepsin activity in Parkinson\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1074\/jbc.RA119.008930","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 McGlinchey et al.","name":"copyright","label":"Copyright"}]}}